117 related articles for article (PubMed ID: 8023830)
1. Profound reversible CD4+ T lymphocytopenia in a severely uremic patient.
Polsky FI; Dannemann B; Hemmert WH
Am J Kidney Dis; 1994 Jul; 24(1):89-91. PubMed ID: 8023830
[TBL] [Abstract][Full Text] [Related]
2. T and B lymphocytes in uremic patients with type B hepatitis infection.
Tong MJ; Bischel MD; Scoles B; Berne TV
Nephron; 1977; 18(3):162-6. PubMed ID: 300854
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis.
Griveas I; Visvardis G; Fleva A; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Ginikopoulou E; Meimaridou D; Paulitou A; Sakellariou G
Ren Fail; 2005; 27(3):279-82. PubMed ID: 15957543
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of T and B lymphocytes in uremic subjects and partial improvement with maintenance hemodialysis.
Hoy WE; Cestero RV; Freeman RB
Nephron; 1978; 20(4):182-8. PubMed ID: 305546
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic CD4+ T-lymphocytopenia--immunodeficiency without evidence of HIV infection.
Ho DD; Cao Y; Zhu T; Farthing C; Wang N; Gu G; Schooley RT; Daar ES
N Engl J Med; 1993 Feb; 328(6):380-5. PubMed ID: 8093634
[TBL] [Abstract][Full Text] [Related]
6. Cellular immunity and levels of parathyroid hormone in uremic patients receiving hemodialysis.
Griveas I; Visvardis G; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Meimaridou D; Ginikopoulou E; Sakellariou G; Fleva A; Zilidou R; Paulitou A
Ren Fail; 2005; 27(3):275-8. PubMed ID: 15957542
[TBL] [Abstract][Full Text] [Related]
7. T lymphocyte subsets and NK cell cytotoxicity in chronic hemodialysis patients. The effect of recombinant human erythropoietin (rHu-EPO) treatment.
Baj Z; Pokoca L; Majewska E; Luciak M; Tchórzewski H
Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):201-6. PubMed ID: 1300984
[TBL] [Abstract][Full Text] [Related]
8. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force.
Smith DK; Neal JJ; Holmberg SD
N Engl J Med; 1993 Feb; 328(6):373-9. PubMed ID: 8093633
[TBL] [Abstract][Full Text] [Related]
9. Immunologic disturbances and levels of parathyroid hormone in uremic patients in replacement dialysis therapy.
Angelini D; Carlini A; Mazzotta L; Mei E; Grassi R; Giusti R; Neri M; Fiorini I; Antonelli A
Clin Nephrol; 1994 Oct; 42(4):246-50. PubMed ID: 7834917
[TBL] [Abstract][Full Text] [Related]
10. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2.
Fernández-Fresnedo G; Ramos MA; González-Pardo MC; de Francisco AL; López-Hoyos M; Arias M
Nephrol Dial Transplant; 2000 Apr; 15(4):502-10. PubMed ID: 10727545
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone and T-cellular immunity in uremic patients in replacement dialytic therapy.
Angelini D; Carlini A; Giusti R; Grassi R; Mei E; Fiorini I; Mazzotta L; Antonelli A
Artif Organs; 1993 Feb; 17(2):73-5. PubMed ID: 8382471
[TBL] [Abstract][Full Text] [Related]
12. T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia.
Laurence J
Ann Intern Med; 1993 Jul; 119(1):55-62. PubMed ID: 8098929
[TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
14. [Recent findings on the pathogenesis and therapy of anemia in chronic kidney failure].
Moccia F; Morra L; Gurreri G
Recenti Prog Med; 1992 Oct; 83(10):572-6. PubMed ID: 1462041
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte subsets in the course of continuous ambulatory peritoneal dialysis.
Grzegorzewska AE; Leander M
Adv Perit Dial; 2001; 17():10-4. PubMed ID: 11510253
[TBL] [Abstract][Full Text] [Related]
16. [Idiopathic CD4+ T-lymphocytopenia terminating in Burkitt's lymphoma].
Shimano S; Murata N; Tsuchiya J
Rinsho Ketsueki; 1997 Jul; 38(7):599-603. PubMed ID: 9267164
[TBL] [Abstract][Full Text] [Related]
17. [Metastatic epidermoid carcinoma in idiopathic CD4+ T lymphocytopenia syndrome].
Michel JL; Perrot JL; Mitanne D; Boucheron S; Fond L; Cambazard F
Ann Dermatol Venereol; 1996; 123(8):478-82. PubMed ID: 9033720
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients.
Pernice F; Floccari F; Nostro L; Caccamo C; Belghity N; Mantuano S; Romeo A; Barilla' A; Aloisi C; Ruello A; Frisina N; Buemi M
J Nephrol; 2006; 19(5):613-20. PubMed ID: 17136690
[TBL] [Abstract][Full Text] [Related]
19. Immune deficiency of the uremic patient.
Chatenoud L; Herbelin A; Beaurain G; Descamps-Latscha B
Adv Nephrol Necker Hosp; 1990; 19():259-74. PubMed ID: 2105582
[No Abstract] [Full Text] [Related]
20. Naïve and central memory T-cell lymphopenia in end-stage renal disease.
Yoon JW; Gollapudi S; Pahl MV; Vaziri ND
Kidney Int; 2006 Jul; 70(2):371-6. PubMed ID: 16738532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
